Elevated value of prostate-specific antigen, progress in imaging, high degree of malignancy in pathology, poor treatment effect, etc. all suggest that prostate cancer is more serious and should be evaluated comprehensively rather than looking at a certain indicator alone. 1. Prostate-specific antigen: it is a specific indicator of prostate cancer, generally speaking, the higher the value is, the more serious the disease is. 2. Imaging: if the prostate MRI or CT examination reveals that there are metastases in other organs, it means that the cancer has developed to the advanced stage and is more serious; the more metastatic foci there are, the more serious the condition is. 3. Pathological results: according to the rules of pathological grading of prostate cancer, it can be categorized into 6~10 points, the higher the score, the higher the degree of malignancy and the more serious the condition. 4. Treatment effect: Generally speaking, patients with good treatment efficacy and stable disease control generally have a relatively mild condition; patients with poor treatment effect and cancer progression after treatment often indicate a more serious condition. At the same time, the severity of the disease needs to be judged by a combination of factors, such as patients with low malignant degree but poor treatment effect are definitely more serious than patients with high malignant degree but good treatment effect. The severity of malignant tumors needs to be assessed systematically, and patients should go to regular hospitals to be examined and evaluated systematically by specialists, and at the same time, follow the doctor’s instructions for treatment.